🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Takashi Yamamura

National Center of Neurology and Psychiatry

ORCID: 0000-0001-9048-0375

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial”.

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

The Lancet Neurology(2020)10.1016/s1474-4422(20)30078-8

N/A

6.8DataRank · unranked

499 citations

Benjamin Greenberg, Jeffrey L. Bennett, L Szczechowski, Edward Fox, Svitlana Shkrobot +8 more

Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.104025

N/A

2.9DataRank · unranked

62 citations

Brian G. Weinshenker, Michael R. Yeaman, de Sèze, Francesco Patti, Patricia Lobo +5 more

Meta-analysis identifies common gut microbiota associated with multiple sclerosis

Genome Medicine(2024)10.1186/s13073-024-01364-x

N/A

0DataRank · unranked

23 citations

Yair Dorsett, Ali Mirza, Helen Tremlett, Laura Piccio, Erin E. Longbrake +9 more